ArticlePoultry science2026
Avian β-defensin 1 as an antibiotic-sparing supplement for preserving rooster semen quality and fertility during chilled storage.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining semen quality during chilled storage is challenging due to bacterial proliferation and oxidative damage, which impair sperm function and fertility. In this study, we evaluated the effects of supplementing a conventional antibiotic and a host-derived antimicrobial peptide in a semen extender on semen quality, bacterial load, and fertility in Thai native roosters during chilled storage. Semen was diluted in an IGGKPh extender supplemented with kanamycin (31.2 µg/mL) or avian β-defensin 1 (AvBD1; 7.5 µg/mL) and stored at 5°C for 0, 24, and 48 h. Data were analyzed using repeated-measures models. At 0 h, both antimicrobial treatments increased total motility and reduced malondialdehyde (MDA) concentrations compared with the control (P < 0.05), whereas viability and acrosome integrity were unaffected. At 24 h, both treatments maintained higher total and progressive motility and acrosome integrity than the control (P < 0.05); viability was higher with AvBD1, whereas MDA concentration was lower with kanamycin. At 48 h, both antimicrobial treatments maintained higher motility, viability, and acrosome integrity and lower MDA concentrations than the control (P < 0.05). Both treatments reduced the viable bacterial load at 0 and 24 h, whereas AvBD1 produced the lowest bacterial load at 48 h (P < 0.05). Fertility was higher in both antimicrobial groups at 0 and 24 h but did not differ among treatments at 48 h. Hatchability was unaffected by antimicrobial treatment. Overall, kanamycin and AvBD1 partially mitigated, but did not prevent, storage-related sperm deterioration. AvBD1 produced broadly similar sperm-quality and fertility responses to kanamycin under controlled storage conditions, supporting its potential as an antibiotic-sparing candidate for short-term poultry semen preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.